Nodality, Inc., a next-generation life sciences company partnering with leading firms to advance precision medicine, announced today results of the Company’s Single Cell Network Profiling (SCNP) technology as reported in two poster presentations at the 104th Annual Meeting of the American Association for Cancer Research (AACR), held in Washington, DC this week.
